Mitochondria-dependent apoptosis was involved in the alleviation of Jujuboside A on diabetic kidney disease-associated renal tubular injury via YY1/PGC-1α signaling
- PMID: 39884075
- DOI: 10.1016/j.phymed.2025.156411
Mitochondria-dependent apoptosis was involved in the alleviation of Jujuboside A on diabetic kidney disease-associated renal tubular injury via YY1/PGC-1α signaling
Abstract
Background: Renal tubular injury was a significant pathological change of diabetic kidney disease (DKD), and the amelioration of renal tubular injury through mitochondrial function was an important treatment strategy of DKD. Our previous study had revealed that Jujuboside A (Ju A), the main active substance isolated from Semen Ziziphi Spinosae (SZS), could restore renal function of diabetic mice. However, its protective mechanism against DKD remains unclear.
Purpose: To investigate the effects and the mechanism of Ju A against DKD-associated renal tubular injury.
Study design and methods: The anti-apoptotic effect of Ju A and its protection effect on mitochondria dysfunction of renal tubular epithelial cells (RTECs) were examined in high glucose (HG)-cultured HK-2 cells, and in db/db mice. Subsequently, Network Pharmacology analysis, molecular docking, luciferase assay, chromatin immunoprecipitation (ChIP), Yin Yang 1 (YY1) overexpression lentiviral vector and peroxisome proliferator-activated receptor-γ coactlvator-1α (PGC-1α) specific agonist ZLN005 were all used to identify the protective mechanism of Ju A towards DKD-associated mitochondrial dysfunction of RTECs.
Results: Ju A inhibited RTECs apoptosis and ameliorated mitochondria dysfunction of RTECs of diabetic mice, and HG-cultured HK-2 cells. YY1 was the potential target of Ju A against DKD-related mitochondrial dysfunction, and the down-regulation of YY1 induced by Ju A increased PGC-1α promoter activity, leading to the restored mitochondrial function of HG-treated HK-2 cells. Renal tubule specific overexpression of YY1 intercepted the renal protective effect of Ju A on diabetic mice via blocking PGC-1α-mediated restoration of mitochondrial function of RTECs. The in-depth mechanism research revealed that the protective effect of Ju A towards DKD-associated renal tubular injury was linked to the restored mitochondrial function through YY1/PGC-1α signaling, resulting in the inhibited apoptosis of RTECs in diabetic condition via inactivating CytC-mediated Caspase9/Caspase3 signaling.
Conclusion: Ju A through the inhibition of mitochondria-dependent apoptosis alleviated DKD-associated renal tubular injury via YY1/PGC-1α signaling.
Keywords: Diabetic kidney disease; Jujuboside A; Mitochondrial function; Renal tubular injury; YY1/PGC-1α signaling.
Copyright © 2025 Elsevier GmbH. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors have declared that there are no conflicts of interest.
Similar articles
-
Tangshenning formula alleviates tubular injury in diabetic kidney disease via the Sestrin2/AMPK/PGC-1α axis: Restoration of mitochondrial function and inhibition of ferroptosis.J Ethnopharmacol. 2025 Apr 9;345:119579. doi: 10.1016/j.jep.2025.119579. Epub 2025 Mar 3. J Ethnopharmacol. 2025. PMID: 40043828
-
Jujuboside A through YY1/CYP2E1 signaling alleviated type 2 diabetes-associated fatty liver disease by ameliorating hepatic lipid accumulation, inflammation, and oxidative stress.Chem Biol Interact. 2024 Sep 1;400:111157. doi: 10.1016/j.cbi.2024.111157. Epub 2024 Jul 24. Chem Biol Interact. 2024. PMID: 39059604
-
Pyruvate kinase M2 activation maintains mitochondrial metabolism by regulating the interaction between HIF-1α and PGC-1α in diabetic kidney disease.Mol Med. 2025 Jul 25;31(1):266. doi: 10.1186/s10020-025-01320-4. Mol Med. 2025. PMID: 40713487 Free PMC article.
-
The Role of Peroxisome Proliferator-Activated Receptor γ Coactivator 1α (PGC-1α) in Kidney Disease.Semin Nephrol. 2018 Mar;38(2):121-126. doi: 10.1016/j.semnephrol.2018.01.003. Semin Nephrol. 2018. PMID: 29602395 Free PMC article. Review.
-
An update on renal tubular injury as related to glycolipid metabolism in diabetic kidney disease.Front Pharmacol. 2025 Apr 24;16:1559026. doi: 10.3389/fphar.2025.1559026. eCollection 2025. Front Pharmacol. 2025. PMID: 40303925 Free PMC article. Review.
Cited by
-
The role of natural products in improving lipid metabolism disorder-induced mitochondrial dysfunction of diabetic kidney disease.Front Physiol. 2025 Jun 24;16:1624077. doi: 10.3389/fphys.2025.1624077. eCollection 2025. Front Physiol. 2025. PMID: 40630391 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous